Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
US Department of Justice
Chubb
Chinese Patent Office
Cantor Fitzgerald
Accenture
McKesson
Cipla

Generated: September 24, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Glimepiride

« Back to Dashboard

Bulk Pharmaceutical API Sources for Glimepiride

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ➤ Try a Free Trial G2295_SIGMA ➤ Try a Free Trial
NIH Clinical Collection ➤ Try a Free Trial SAM001246710 ➤ Try a Free Trial
Hangzhou Trylead Chemical Technology ➤ Try a Free Trial TL8005924 ➤ Try a Free Trial
NovoSeek ➤ Try a Free Trial 3476 ➤ Try a Free Trial
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Accenture
Citi
McKesson
Moodys
Federal Trade Commission
Boehringer Ingelheim
Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.